October 20, 2007 -- Globally, M&A activity dropped 42% in Q3. Against that negative backdrop, the largest pharmacy chain in China, China Nepstar announced its IPO; current IPO star WuXi PharmaTech hit a new high on Thursday; China Medical said its high intensity focused ultrasound (HIFU) tumor therapy system won Korean approval; Beijing Med-Pharm announced a new deal to distribute Ferriprox®; China Biopharma, said its partner completed a trial production run of its topical antiviral; China Pharma continued its meteoric rise; and Renhuang Pharma is attempting to get its story out to investors. More details...
